| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 76-43-7 | 氟甲睪酮; 氟羥甲基睪丸酮 | Fluoxymesterone; 9a-Fluoro-11b,17b-dihydroxy-17a-methyl-4-androsten-3-one |  | C20H29FO3 | 詳情 | 供應商 |
| 671-35-2 | 5-氟-3H-嘧啶-4-酮; 5-氟-4-羥基嘧啶; 4-羥基-5-氟嘧啶 | Fluoxydine; 5-Fluoro-3H-pyrimidin-4-one; 5-Fluoro-4(1H)-pyrimidinone; 5-Fluor-4-pyrimidinol; 4-Hydroxy-5-fluorpyrimidine |  | C4H3FN2O | 詳情 | 供應商 |
| 54910-89-3 | 氟西汀; N-甲基-3-苯基-3-(對三氟甲基苯氧基)丙胺 | Fluoxetine; (+/-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine |  | C17H18F3NO | 詳情 | 供應商 |
| 56296-78-7 | 鹽酸氟西汀; (+/-)-N-甲基-3-(對三氟甲基苯氧基)-3-苯基丙胺鹽酸鹽 | Fluoxetine hydrochloride; Methyl[3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]amine hydrochloride; N-Methyl-gama-[4-(trifluoromethyl) |  | C17H19ClF3NO | 詳情 | 供應商 |
| 91296-86-5 | 鹽酸二氟沙星; 6-氟-1-(4-氟苯基)-7-(4-甲基哌嗪-1-基)-4-氧代喹啉-3-羧酸鹽酸鹽 | DiFluoxacin hydrochloride; 6-Fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid hydrochloride |  | C21H20ClF2N3O3 | 詳情 | 供應商 |
| 114247-09-5 | R-氟西汀; N-甲基-gamma-[4-(三氟甲基)-苯氧基]-苯丙胺 | R-(-)-Fluoxetine hydrochloride |  | C17H18F3NO | 詳情 | 供應商 |
| 127685-30-7 | Benzenepropanamine, g-[4-(trifluoromethyl)phenoxy]-,hydrochloride (1:1), (gS)-; Benzenepropanamine,g-[4-(trifluoromethyl)phenoxy]-,hydrochloride, (S)-; Benzenepropanamine, g-[4-(trifluoromethyl)phenoxy]-, hydrochloride, (gS)- (9CI); (S)-NorFluoxetinehydrochloride; LY 215229 hydrochloride; Seproxetine hydrochloride |  | C16H17ClF3NO | 詳情 | 供應商 | |
| 361377-29-9 | 氟嘧菌酯; 氟嘧菌酯 | FluoxASTROBIN; Methanone, 2-6-(2-chlorophenoxy)-5-fluoro-4-pyrimidinyloxyphenyl(5,6-dihydro-1,4,2-dioxazin-3-yl)-, O-methyloxime, (1E)-; hec5725; (Z)-1-(2-{[6-(2-chlorophenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-1-(5,6-dihydro-1,4,2-dioxazin-3-yl)-N-methoxymethanimine; Fluxastrobin |  | C21H16ClFN4O5 | 詳情 | 供應商 |